Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations.
BACKGROUND: Type 2 diabetes (T2D) is increasing its burden worldwide; therefore, research focused on its prediction and prevention is essential. METHODS: We performed an untargeted metabolomics analysis using ultra high-performance liquid chromatography-mass spectrometry to discover metabolic biomar...
| Autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Fundació Sant Joan de Déu |
| Repositorio: | r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| OAI Identifier: | oai:fsjd.fundanetsuite.com:p29747 |
| Acceso en línea: | https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=29747 |
| Access Level: | acceso abierto |
| Palabra clave: | incident type 2 diabetes liquid chromatography mass spectrometry targeted metabolomics untargeted metabolomics |
| id |
ES_47962e1dd3cf8a11255b7c395f4e47ba |
|---|---|
| oai_identifier_str |
oai:fsjd.fundanetsuite.com:p29747 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations.Barranco, M.Granado, MinervaYanes, OscarCapellades, JordiJunza, AlexandraFranch, JosepVendrell, JoanLlauradó, GemmaValdés, SergioGarcía, EvaBermúdez, MarcelinoValdivieso, José ManuelLópez, Víctor MiguelHerrero, CeliaFalguera, MireiaVilanova, María BelénArteaga, IngridTorán, PerePerera, A.Castelblanco, EsmeraldaMauricio, Dídacincident type 2 diabetesliquid chromatographymass spectrometrytargeted metabolomicsuntargeted metabolomicsBACKGROUND: Type 2 diabetes (T2D) is increasing its burden worldwide; therefore, research focused on its prediction and prevention is essential. METHODS: We performed an untargeted metabolomics analysis using ultra high-performance liquid chromatography-mass spectrometry to discover metabolic biomarkers and biological pathways associated with incident T2D with a nested case-control design, followed by validation with targeted metabolomics in an independent cohort. In the discovery phase, plasma samples from 352 subjects (209 controls and 143 incident cases) were analyzed, collected with a mean (standard deviation) of 7.40 (0.76) years before they acquired the condition. Using this discovery phase cohort, six metabolites were identified using standards and were subsequently quantified in an independent validation phase cohort of 2,044 subjects (167 incident cases). Additionally, pathway enrichment was conducted in the discovery cohort. RESULTS: Guanine, ecgonine, adenine, pregnenolone sulfate, phenyl sulfate, and citrulline were significantly associated with incident T2D in at least one of the analyses performed in the discovery phase. Among these, guanine, pregnenolone sulfate, and citrulline maintained their significant associations with incident T2D in the validation cohort. Additionally, several pathways were significantly altered, with nucleotide metabolism and ABC transporter pathways among the most consistently affected. CONCLUSION: We identified significant associations of guanine, pregnenolone sulfate, and citrulline with incident T2D.FRONTIERS MEDIA SA2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=29747Frontiers in EndocrinologyISSN: 16642392reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déuinstname:Fundació Sant Joan de DéuInglésinfo:eu-repo/semantics/openAccessoai:fsjd.fundanetsuite.com:p297472026-05-27T12:37:41Z |
| dc.title.none.fl_str_mv |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| title |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| spellingShingle |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. Barranco, M. incident type 2 diabetes liquid chromatography mass spectrometry targeted metabolomics untargeted metabolomics |
| title_short |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| title_full |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| title_fullStr |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| title_full_unstemmed |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| title_sort |
Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations. |
| dc.creator.none.fl_str_mv |
Barranco, M. Granado, Minerva Yanes, Oscar Capellades, Jordi Junza, Alexandra Franch, Josep Vendrell, Joan Llauradó, Gemma Valdés, Sergio García, Eva Bermúdez, Marcelino Valdivieso, José Manuel López, Víctor Miguel Herrero, Celia Falguera, Mireia Vilanova, María Belén Arteaga, Ingrid Torán, Pere Perera, A. Castelblanco, Esmeralda Mauricio, Dídac |
| author |
Barranco, M. |
| author_facet |
Barranco, M. Granado, Minerva Yanes, Oscar Capellades, Jordi Junza, Alexandra Franch, Josep Vendrell, Joan Llauradó, Gemma Valdés, Sergio García, Eva Bermúdez, Marcelino Valdivieso, José Manuel López, Víctor Miguel Herrero, Celia Falguera, Mireia Vilanova, María Belén Arteaga, Ingrid Torán, Pere Perera, A. Castelblanco, Esmeralda Mauricio, Dídac |
| author_role |
author |
| author2 |
Granado, Minerva Yanes, Oscar Capellades, Jordi Junza, Alexandra Franch, Josep Vendrell, Joan Llauradó, Gemma Valdés, Sergio García, Eva Bermúdez, Marcelino Valdivieso, José Manuel López, Víctor Miguel Herrero, Celia Falguera, Mireia Vilanova, María Belén Arteaga, Ingrid Torán, Pere Perera, A. Castelblanco, Esmeralda Mauricio, Dídac |
| author2_role |
author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
incident type 2 diabetes liquid chromatography mass spectrometry targeted metabolomics untargeted metabolomics |
| topic |
incident type 2 diabetes liquid chromatography mass spectrometry targeted metabolomics untargeted metabolomics |
| description |
BACKGROUND: Type 2 diabetes (T2D) is increasing its burden worldwide; therefore, research focused on its prediction and prevention is essential. METHODS: We performed an untargeted metabolomics analysis using ultra high-performance liquid chromatography-mass spectrometry to discover metabolic biomarkers and biological pathways associated with incident T2D with a nested case-control design, followed by validation with targeted metabolomics in an independent cohort. In the discovery phase, plasma samples from 352 subjects (209 controls and 143 incident cases) were analyzed, collected with a mean (standard deviation) of 7.40 (0.76) years before they acquired the condition. Using this discovery phase cohort, six metabolites were identified using standards and were subsequently quantified in an independent validation phase cohort of 2,044 subjects (167 incident cases). Additionally, pathway enrichment was conducted in the discovery cohort. RESULTS: Guanine, ecgonine, adenine, pregnenolone sulfate, phenyl sulfate, and citrulline were significantly associated with incident T2D in at least one of the analyses performed in the discovery phase. Among these, guanine, pregnenolone sulfate, and citrulline maintained their significant associations with incident T2D in the validation cohort. Additionally, several pathways were significantly altered, with nucleotide metabolism and ABC transporter pathways among the most consistently affected. CONCLUSION: We identified significant associations of guanine, pregnenolone sulfate, and citrulline with incident T2D. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=29747 |
| url |
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=29747 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
FRONTIERS MEDIA SA |
| publisher.none.fl_str_mv |
FRONTIERS MEDIA SA |
| dc.source.none.fl_str_mv |
Frontiers in Endocrinology ISSN: 16642392 reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu instname:Fundació Sant Joan de Déu |
| instname_str |
Fundació Sant Joan de Déu |
| reponame_str |
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| collection |
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869407304246362112 |
| score |
15.81155 |